Arca
Skip to content
Tools
Tools

Label Changes: Yervoy (ipilimumab)

A drug's label (its prescribing information) is revised many times after approval: new warnings, new uses, new doses. DailyMed keeps every version. Pick a drug to see them all and what changed between any two.

Every version of the Yervoy label DailyMed has published, from E.R. Squibb & Sons, L.L.C., and what changed between any two of them, section by section. Current label on DailyMed.

  • Versions on DailyMed: 44
  • Sections changed, version 46 to 47: 2

What changed from version 46 to version 47

Aug 7, 2026 to Aug 26, 2026, as published on DailyMed. Added text is underlined in green, removed text struck through in red.
  1. Dosage and administrationChanged ยท 49 words added, 49 removed
  2. Warnings and precautionsChanged ยท 25 words added, 3 removed

Dosage and administration

Changed49 words added, 49 removed
8 unchanged lines
Esophageal Cancer
โ€ขSelect patients with unresectable or advanced or metastatic ESCC for treatment with YERVOY in combination with nivolumab based on PD-L1 expression [see Clinical Studies (14.8)].
โ€ขSelect patients with unresectable or advanced or metastatic ESCC for treatment with YERVOY in combination with nivolumab based on PD-L1 expression [see Clinical Studies (14.8)]. โˆ˜An FDA-authorized companion diagnostic for the detection of PD-L1 expression in patients with advanced or metastatic ESCC is not available.
โ€ขAn FDA-authorized companion diagnostic for the detection of PD-L1 expression in patients with advanced or metastatic ESCC is not available.
2.2 Recommended Dosage
64 unchanged lines

Warnings and precautions

Changed25 words added, 3 removed
92 unchanged lines
Musculoskeletal and Connective Tissue: Arthritis, myositis, polymyalgia rheumatica, polymyositis, rhabdomyolysis
Other (hematologicHematologic/immune)Immune: Aplastic anemia, conjunctivitis, cytopenias (2.5%), eosinophilia (2.1%), erythema multiforme, histiocytic necrotizing lymphadenitis (Kikuchi lymphadenitis), hypersensitivity vasculitis, meningitis, neurosensory hypoacusis, psoriasis, sarcoidosis, systemic inflammatory response syndrome, and solid organ transplant rejection.
Other: Myocarditis-Myositis-Myasthenia Gravis (or Myasthenia-Like) Overlap Syndrome, reported as the co-occurrence of either two or all three adverse reactions.
5.2 Infusion-Related Reactions
8 unchanged lines

Unchanged: Indications and usage, Dosage forms and strengths, Contraindications, Adverse reactions, Use in specific populations, Description, Clinical pharmacology, Nonclinical toxicology, Clinical studies, How supplied, Patient counseling information, Medication guide, YERVOY 50 mg/10 mL Representative Packaging, YERVOY 200 mg/40 mL Representative Packaging.

Every version

44 versions of set 2265ef30-253e-11df-8a39-0800200c9a66, newest first.
VersionPublished on DailyMedCompareSPL file
47Aug 26, 2026Shown belowDownload .zip
46Aug 7, 2026With version 45Download .zip
45Jun 9, 2025With version 44Download .zip
44Apr 28, 2025With version 43Download .zip
43Feb 13, 2025With version 42Download .zip
42Jun 30, 2023With version 41Download .zip
41Mar 9, 2023With version 40Download .zip
40Jan 27, 2023With version 39Download .zip
39Dec 8, 2022With version 38Download .zip
38Jun 14, 2022With version 37Download .zip
37May 25, 2022With version 36Download .zip
36May 12, 2022With version 35Download .zip
35Jun 7, 2021With version 34Download .zip
34Nov 25, 2020With version 33Download .zip
33Oct 16, 2020With version 32Download .zip
32Oct 5, 2020With version 31Download .zip
31Aug 20, 2020With version 30Download .zip
30Jul 10, 2020With version 29Download .zip
29Jun 8, 2020With version 28Download .zip
28May 28, 2020With version 27Download .zip
27Apr 1, 2020With version 26Download .zip
26Oct 2, 2019With version 25Download .zip
25May 14, 2019With version 24Download .zip
24Dec 27, 2018With version 23Download .zip
23Jul 20, 2018With version 22Download .zip
22Apr 25, 2018With version 21Download .zip
21Feb 20, 2018With version 20Download .zip
20Dec 22, 2017With version 19Download .zip
19Oct 31, 2017With version 18Download .zip
18Aug 2, 2017With version 17Download .zip
17Mar 16, 2017With version 16Download .zip
16Oct 17, 2016With version 15Download .zip
15Sep 6, 2016With version 14Download .zip
14Apr 11, 2016With version 13Download .zip
13Mar 9, 2016With version 12Download .zip
12Nov 10, 2015With version 11Download .zip
11Aug 28, 2015With version 10Download .zip
10Apr 2, 2015With version 9Download .zip
9Dec 20, 2013With version 8Download .zip
8Jun 10, 2013With version 7Download .zip
7Feb 8, 2013With version 6Download .zip
6Nov 15, 2012With version 5Download .zip
5Sep 13, 2011With version 3Download .zip
3Apr 4, 2011First versionDownload .zip

Read an SPL file

Open an SPL label file

Drop a Structured Product Labeling .xml file, or the .zip DailyMed downloads, to read it as a label. It is read in this browser tab and not uploaded.

Read in this browser tab; nothing is uploaded.

Versions and label text from DailyMed's SPL web services; a version's text is read from its SPL file, so it matches what DailyMed shows. Recent safety-related changes from FDA's Safety-related Labeling Changes database, which covers NDAs and CDER biologics, not generics. Lists refresh daily. DailyMed, National Library of Medicine

About label change history

How to read a comparison

Sections that changed come first, in the order a reviewer reads a label: boxed warning, recent major changes, indications, dosage, contraindications, warnings and precautions, adverse reactions, then the rest. Each shows the changed lines with one unchanged line either side; longer unchanged stretches are folded into a count. Table rows read left to right with cells separated by a bar.

The comparison covers the label text. Images, product data (NDC codes, ingredients, packaging) and formatting are not compared.

Which label is shown

A drug can have several labels: one per brand-name application (Ozempic, Wegovy and Rybelsus are three), and copies from repackagers. For each NDA or BLA the page takes the DailyMed set with the most versions, which is the application holder's. Generic labels are left out; they follow the brand's label.

Frequently asked questions

Where do the versions come from?
DailyMed, the National Library of Medicine's library of labels in Structured Product Labeling (SPL) format. Each time a company submits a revised label, DailyMed publishes it as a new version of the same set and keeps the old ones.
Is a new version a new FDA approval?
Not always. Companies also submit new versions for changes that need no FDA approval first, such as a new address, a new package size or a corrected typo. Safety changes FDA approved are listed in its Safety-related Labeling Changes database, linked below.
Why does the published date differ from the label's revised date?
The published date is when DailyMed posted the version. The label's own revised date, at the end of the highlights, is when the company revised the text, usually a few days to weeks earlier.
How is the comparison made?
Each section is matched by its standard LOINC code, then split into headings, paragraphs, list items and table rows. Lines are aligned with a longest-common-subsequence diff; a removed and an added line that share at least half their words are shown as one edited line with the changed words marked. Curly quotes, dash styles and spacing are ignored.
Is my SPL file uploaded?
No. A file you drop on this page is read in your browser tab and never sent to Arca.
Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.